uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$6.0100
+0.2300 ( +2.39% ) 233.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$6.0100

Previous close


$5.7800

Volume


233.7K

Market cap


$301.72M

Day range


$5.7800 - $6.2350

52 week range


$3.7300 - $11.3500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 21, 2024
10-q Quarterly Reports 70 Nov 05, 2024
8-k 8K-related 15 Nov 05, 2024
8-k 8K-related 15 Oct 15, 2024
8-k 8K-related 15 Sep 23, 2024
8-k 8K-related 15 Aug 15, 2024
8-k 8K-related 15 Aug 01, 2024
10-q Quarterly Reports 72 Aug 01, 2024
8-k 8K-related 15 Jul 23, 2024
8-k 8K-related 15 Jul 09, 2024

Latest News